Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer
Abstract
Share and Cite
Manso, L.; Moreno, F.; Márquez, R.; Castelo, B.; Arcediano, A.; Arroyo, M.; Ballesteros, A.I.; Calvo, I.; Echarri, M.J.; Enrech, S.; et al. Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer. Curr. Oncol. 2015, 22, 51-60. https://doi.org/10.3747/co.22.2210
Manso L, Moreno F, Márquez R, Castelo B, Arcediano A, Arroyo M, Ballesteros AI, Calvo I, Echarri MJ, Enrech S, et al. Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer. Current Oncology. 2015; 22(2):51-60. https://doi.org/10.3747/co.22.2210
Chicago/Turabian StyleManso, L., F. Moreno, R. Márquez, B. Castelo, A. Arcediano, M. Arroyo, A.I. Ballesteros, I. Calvo, M.J. Echarri, S. Enrech, and et al. 2015. "Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer" Current Oncology 22, no. 2: 51-60. https://doi.org/10.3747/co.22.2210